Oramed Pharmaceuticals Inc. (ORMP): Prakiraan wutah bathi resik saben saham kanggo taun ngarep
The earnings per share growth forecast trend on GURU.Markets shows that 0.00 is the current metric. Oramed Pharmaceuticals (ORMP) attracts leading biochemists due to the uniqueness of its developments. Business stability is guaranteed by the patented POD system, which protects proteins in the gastrointestinal tract. Efficiency is enhanced through the robotization of dosing lines, which significantly reduces manual labor costs in the production of capsule insulin.
Rincian analitis lan laporan data perusahaan Oramed Pharmaceuticals Inc. (ORMP)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- rincian nilai buku perusahaan:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Oramed Pharmaceuticals|ORMP - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Oramed|ORMP - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Oramed Pharmaceuticals|ORMP - Utang jangka dawa|Utang jangka cendhak perusahaan Oramed Pharmaceuticals|Indikator likuiditas cepet oramed.com
- data bathi resik lan rasio valuasi:
ORMP - Bathi pungkasan|Bathi sing dikarepake Oramed Pharmaceuticals|ORMP - Kapitalisasi marang bathi resik|Pangali Forward P/E Oramed|ORMP - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Oramed Pharmaceuticals|ORMP - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Oramed Pharmaceuticals|ORMP - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan oramed.com|ORMP - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Oramed Pharmaceuticals
- data total pendapatan lan volume dodolan:
Analisis komprehensif perusahaan:Oramed Pharmaceuticals, ORMP
Oramed Pharmaceuticals profit dynamics are sensitive to external market shocks and competition in the US. However, strong liquidity and Nadav Kidron's strategic approach create a substantial margin of safety for the business. By analyzing the projected EPS growth rate for next year, an investor assesses analyst consensus expectations, which allows for the timely detection of shifts in institutional sentiment and a reassessment of the asset's risks.
Pesaing Oramed Pharmaceuticals
HLN (Haleon Group) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kenvue Health KVUE|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ligand LGND|Amneal Pharmaceuticals, Inc. (AMRX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|PRGO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep ALVO (Alvotech Biopharmaceuticals)|LQDA: Prakiraan wutah bathi kanggo taun ngarep|glpg.com (GLPG) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ANI Pharmaceuticals, Inc.|Prakiraan wutah bathi saben saham kanggo taun ngarep MannKind Corp (MNKD)|Prakiraan wutah bathi kanggo taun ngarep AMPH|PCRX - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SPRY (ARS Pharmaceuticals)|TBPH: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|AQST: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep SCPH (scPharmaceuticals Inc.)|tectonictx.com (TECX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TNXP (Tonix Pharmaceuticals Holding)|SXTC (SXT Pharmaceuticals) - Prakiraan wutah bathi kanggo taun ngarep|EPRX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep BHST|Prakiraan wutah bathi kanggo taun ngarep Invizyne Technologies (EXOZ)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Entera Bio ENTX|Dinamika bathi saben saham sing diarepake ing taun ngarep HYFT|ABVC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|cumberlandpharma.com (CPIX) - Prakiraan wutah bathi saben saham kanggo taun ngarep|QNTM: Prakiraan wutah bathi kanggo taun ngarep|FibroGen Inc (FGEN) - Prakiraan wutah bathi kanggo taun ngarep|TELO (Telomir Pharma) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Rani Therapeutics Inc (RANI)|Prakiraan wutah bathi kanggo taun ngarep SNYR|RLYB - Prakiraan wutah bathi resik saben saham ing taun ngarep|Lexaria Bioscience Corp. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Pulmatrix Inc PULM|PTHL: Prakiraan wutah bathi saben saham kanggo taun ngarep|Aptorum Group Limited - Proyeksi tambahing bathi saben saham ing taun ngarep|LYRA: Prakiraan wutah bathi kanggo taun ngarep|IBO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|TNFA (TNF Pharmaceuticals Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep cbdMD Corp (YCBD)|Prakiraan wutah bathi kanggo taun ngarep PRFX|Prakiraan wutah bathi kanggo taun ngarep altamiratherapeutics.com (CYTO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lipella Pharmaceuticals LIPO|optinose.com - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|PIRS - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Procaps Group PROC|Petros (PTPI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Qilian International Corp (QLI)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Acelyrin, Inc.|TFFP: Dinamika bathi saben saham sing diarepake ing taun ngarep
